According to a series of news reports, about 500,000 patients in the United States received an artificial hip transplant that has failed and because of that, the Food and Drug Administration has proposed new rules that would keep manufacturers from selling the dangerous and potentially hazardous implants. The reports show that the FDA hopes to make all artificial hip implants produced with all-metal components would have to prove the device is safe before the federal agency may consider allowing the (read more)
Read MoreIt’s been extensively reported in the news that Rejuvenate Modular and ABG II modular-neck hip implants are being recalled over potential risks associated with the corrosion and fretting these stems may experience at its junctions, which could even result in risky adverse reactions, swelling and pain. The company Stryker Orthopaedics has decided to issue this recall announcement following the discoveries that these particular implants could pose a health issue to patients and to prevent possible adverse reactions in the future, the company (read more)
Read MoreIt’s been noted by the Food and Drug Administration and several news agencies that metal hip replacements may have been exposing patients to highly dangerous levels of toxins, which could pose a serious health risk over time. According to the series of news articles mentioning this problem, millions of patients who have the metal-on-metal hip implants have had metal particles seeping into their bloodstream, which could destroy muscle and bone since chromium and cobalt irons were found in these artificial types of (read more)
Read More
24
Aug
2011
J&J Outsources DePuy ASR Hip Implant Recall
Recent news reports indicate that Johnson & Johnson is hiring an outside firm to handle the recall of its DePuy ASR hip implant, an unusual decision that may limit its financial exposure and patients’ access to replacement hip devices. J&J has hired Broadspire Services Inc to manage patient claims related to the recall. Most companies would handle something like this in-house, accepting physicians’ judgments about whether a revision surgery is needed. But the outsourcing of this process means that Broadspire’s (read more)
Read MoreDePuy hip replacement recall calls demonstrates perpetual cycle of corporate interests trumping those of individuals. DePuy hip recall lawsuits (800) 232-7070
Read MoreThe cases of DePuy artificial hip failure have all been consolidated to one court in Ohio. Patients hope to gain compensation for pain and suffering.
Read MoreLarge pharmaceutical companies will pay doctors to promote their product. A database shows the doctors who have been asked to promote drugs.
Read MoreTaxpayers face the financial burden of paying for costly hip revision surgeries, because Medicare and Medicaid fund half of hip replacements.
Read More
17
Nov
2010
DePuy Ads Misled Hip Replacement Patients
Ads for the DePuy ASR XL Acetabular hip implant system were misleading to younger patients.
Read More